Northern Trust’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.54K | Hold |
|
|||||
|
2023
Q2 | $3.63K | Hold |
|
|||||
|
2023
Q1 | $10.2K | Hold |
|
|||||
|
2022
Q4 | $8.28K | Hold |
|
|||||
|
2022
Q3 | $10K | Hold |
|
|||||
|
2022
Q2 | $28K | Hold |
|
|||||
|
2022
Q1 | $31K | Hold |
|
|||||
|
2021
Q4 | $39K | Hold |
|
|||||
|
2021
Q3 | $69K | Hold |
|
|||||
|
2021
Q2 | $72K | Hold |
|
|||||
|
2021
Q1 | $80K | Buy |
|
|||||
|
2020
Q4 | $83K | Buy |
|
|||||
|
2020
Q3 | $97K | Sell |
|
|||||
|
2020
Q2 | $180K | Buy |
|
|||||
|
2020
Q1 | $16K | Hold |
|
|||||
|
2019
Q4 | $27K | Buy |
|
|||||
|
2019
Q3 | $8K | Hold |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $34K | Hold |
|
|||||
|
2018
Q4 | $26K | Hold |
|
|||||
|
2018
Q3 | $57K | Hold |
|
|||||
|
2018
Q2 | $56K | Hold |
|
|||||
|
2018
Q1 | $88K | Hold |
|
|||||
|
2017
Q4 | $87K | Hold |
|
|||||
|
2017
Q3 | $102K | Hold |
|
|||||
|
2017
Q2 | $124K | Sell |
|
|||||
|
2017
Q1 | $141K | Buy |
|
|||||
|
2016
Q4 | $143K | Buy |
|
|||||
|
2016
Q3 | $198K | Sell |
|
|||||
|
2016
Q2 | $115K | Sell |
|
|||||
|
2016
Q1 | $1.46M | Sell |
|
|||||
|
2015
Q4 | $2.06M | Buy |
|
|||||
|
2015
Q3 | $3.45M | Buy |
|
|||||
|
2015
Q2 | $2.42M | Sell |
|
|||||
|
2015
Q1 | $2.48M | Buy |
|
|||||
|
2014
Q4 | $2.83M | Sell |
|
|||||
|
2014
Q3 | $2.09M | Buy |
|
|||||
|
2014
Q2 | $2.07M | Sell |
|
|||||
|
2014
Q1 | $2.81M | Sell |
|
|||||
|
2013
Q4 | $3.48M | Buy |
|
|||||
|
2013
Q3 | $4.41M | Buy |
|
|||||
|
2013
Q2 | $4.19M | Buy |
|